Anaplastic lymphoma kinase fusions: Roles in cancer and therapeutic perspectives (Review)Zhifa Cao, Wen‐Bin Ou|Oncology Letters|2018Cited by 55
HDACi inhibits liposarcoma via targeting of the MDM2-p53 signaling axis and PTEN, irrespective of p53 mutational statusWen‐Bin Ou, Jonathan A. Fletcher|Oncotarget|2015Cited by 37
YWHAE-NUTM2 oncoprotein regulates proliferation and cyclin D1 via RAF/MAPK and Hippo pathwaysWen‐Bin Ou, Jonathan A. Fletcher|Oncogenesis|2021Cited by 35
Co-targeting of FAK and MDM2 triggers additive anti-proliferative effects in mesothelioma via a coordinated reactivation of p53Wen‐Bin Ou, Jonathan A. Fletcher|British Journal of Cancer|2016Cited by 33
Downregulation of cyclin D1 sensitizes cancer cells to MDM2 antagonist Nutlin-3Peipei Yang, Wen‐Bin Ou|Oncotarget|2016Cited by 21